{"ok":true,"trend":{"id":448808,"platform":"news","region":"global","key":"biotech lagged the broader market in september — did retail favorites sls, ibrx, vnda and iova dodge xbi’s slump?","title":"Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump?","url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOOE8yUlplN1FmcHpJMGMzX2dhS2JsUE94cWExTEU3TEJZak9EcEZVbDN6cV91LXBlWmgydkozdGZNdlF0TmphcDF1YnUtS0xoa1ExSXNfUXpZX3ZEakJhYkRkMzVCWVp5Wmtldm85LUdZT3o0aFdtbkRVaG5rdl8yOE1jaEs3c1FNM25Qb2N3MkNWUGlOdmRnUjdpc1ROcUstZEE?oc=5","first_seen":"2026-09-30T05:58:52.187428Z","last_seen":"2026-09-30T12:48:53.280790Z","last_rank":33,"peak_rank":5,"last_volume":null,"peak_volume":0,"seen_count":3,"score":0.721875,"category_hint":"retail","section":"business","category":"retail","summary":"Biotech stocks lagged the broader market in September, with the SPDR S&P Biotech ETF (XBI) falling while the wider market held up better. Attention is now on whether retail-favored names SELLAS Life Sciences (SLS), ImmunityBio (IBRX), Vanda Pharmaceuticals (VNDA) and Iovance Biotherapeutics (IOVA) managed to escape the sector's slump. Investors are weighing whether these popular small-cap biotechs diverged from the wider sector weakness.","why":"Biotech underperformed the broader market last month, prompting retail investors to check whether their favorite small-cap names bucked the trend.","tone":"neutral","entities":["SELLAS Life Sciences (SLS)","ImmunityBio (IBRX)","Vanda Pharmaceuticals (VNDA)","Iovance Biotherapeutics (IOVA)","XBI biotech ETF"],"summarized_at":"2026-09-30T05:59:07.343831Z","meta":{"via":"scan","lang":"en","term":"retail","source":"finance.yahoo.com","published":"Wed, 30 Sep 2026 03:47:00 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Retail biotech favorites SLS, IBRX, VNDA, IOVA vs September slump","section_name":"Business","category_name":"Retail","timeline":[{"captured_at":"2026-09-30T05:58:52.187428Z","rank":5,"volume":null},{"captured_at":"2026-09-30T11:26:51.817607Z","rank":19,"volume":null},{"captured_at":"2026-09-30T12:48:53.280790Z","rank":33,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOOE8yUlplN1FmcHpJMGMzX2dhS2JsUE94cWExTEU3TEJZak9EcEZVbDN6cV91LXBlWmgydkozdGZNdlF0TmphcDF1YnUtS0xoa1ExSXNfUXpZX3ZEakJhYkRkMzVCWVp5Wmtldm85LUdZT3o0aFdtbkRVaG5rdl8yOE1jaEs3c1FNM25Qb2N3MkNWUGlOdmRnUjdpc1ROcUstZEE?oc=5","author":"Yahoo Finance","title":"Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump?","snippet":null,"posted_at":"2026-09-30T03:47:00Z","likes":null}],"elsewhere":[],"window":"7d"}}